日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.

中和作用和ADCC揭示了非洲人群中不同SARS-CoV-2疫苗平台对刺突蛋白亚结构域的靶向作用存在差异。

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.114351
Oluka Gerald Kevin, Katende Joseph Ssebwana, Kato Laban, Ankunda Violet, Sembera Jackson, Ejou Peter, Odoch Geoffrey, Namuyanja Angella, Kaleebu Pontiano, Serwanga Jennifer
DCC
SARS-CoV-2
发表日期：2026
文献求助 收藏

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

SARS-CoV-2 抗体反应动态和对轻症 COVID-19 的中和特征的地域差异：来自英国和乌干达的比较经验

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13040336
Kato Laban, Sembera Jackson, Oluka Gerald Kevin, Katende Joseph Ssebwana, Bemanzi Juliana, Ankunda Violet, Ejou Peter, Kurshan Ashwini, Graham Carl, Seow Jeffrey, Doores Katie J, Malim Michael H, Fox Julie M, Kaleebu Pontiano, Serwanga Jennifer
炎症/感染
新冠
发表日期：2025
文献求助 收藏

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.

SARS-CoV-2 刺突糖蛋白编码的改良型自扩增核糖核酸 (saRNA) 疫苗在 SARS-CoV-2 血清阴性和血清阳性乌干达个体中的安全性和免疫原性

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13060553
Kitonsa Jonathan, Serwanga Jennifer, Cheeseman Hannah M, Abaasa Andrew, Lunkuse Jane Frances, Ruzagira Eugene, Kato Laban, Nambaziira Florence, Oluka Gerald Kevin, Gombe Ben, Jackson Sembera, Ssebwana Joseph Katende, McFarlane Leon R, Joseph Sarah, Pierce Benjamin F, Shattock Robin J, Kaleebu Pontiano
炎症/感染
新冠
发表日期：2025
文献求助 收藏

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

初次接触 SARS-CoV-2 A.23.1 的长期免疫后果：乌干达人群抗体反应和交叉中和的纵向研究

期刊:Vaccines
影响因子:
doi:10.3390/vaccines13020143
Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan, Carl Graham, Jeffrey Seow, Katie J Doores, Michael H Malim, Julie M Fox, Pontiano Kaleebu, Jennifer Serwanga
免疫
新冠
发表日期：2025
文献求助 收藏

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

乌干达接种辉瑞-BioNTech BNT162b2疫苗后，加强免疫后针对刺突蛋白的二次IgG抗体反应较弱，这对当地的疫苗接种政策具有重要意义。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1325387
Ankunda, Violet; Katende, Joseph Ssebwana; Oluka, Gerald Kevin; Sembera, Jackson; Baine, Claire; Odoch, Geoffrey; Ejou, Peter; Kato, Laban; Kaleebu, Pontiano; Serwanga, Jennifer
IgG
免疫/内分泌
发表日期：2024
文献求助 收藏

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

在乌干达不同基线免疫特征的人群中，均观察到对牛津-阿斯利康（ChAdOx1-S，Covishield）SARS-CoV-2疫苗ChAdOx1-S的持续且强效的抗体反应。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0303113
Serwanga, Jennifer; Oluka, Gerald Kevin; Baine, Claire; Ankunda, Violet; Sembera, Jackson; Kato, Laban; Katende, Joseph Ssebwana; Odoch, Geoffrey; Auma, Betty Oliver; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano
SARS-CoV-2
免疫/内分泌
发表日期：2024
文献求助 收藏

Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals

在撒哈拉以南非洲地区接种科兴疫苗后，可产生持续的刺突蛋白特异性IgG抗体，但基线未接种过刺突蛋白疫苗的人群中突破性感染发生率增加。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1255676
Sembera, Jackson; Baine, Claire; Ankunda, Violet; Katende, Joseph Ssebwana; Oluka, Gerald Kevin; Akoli, Christine Hermilia; Kato, Laban; Odoch, Geoffrey; Ejou, Peter; Opio, Solomon; Musenero, Monica; Kaleebu, Pontiano; Serwanga, Jennifer
炎症/感染
IgG
发表日期：2023
文献求助 收藏

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

乌干达既往感染过轻症或无症状新冠肺炎患者接种阿斯利康疫苗后抗体反应的血清阳性率和持久性：对疫苗政策的启示

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1183983
Serwanga, Jennifer; Baine, Claire; Mugaba, Susan; Ankunda, Violet; Auma, Betty Oliver; Oluka, Gerald Kevin; Kato, Laban; Kitabye, Isaac; Sembera, Jackson; Odoch, Geoffrey; Ejou, Peter; Nalumansi, Amina; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano
肺炎
新冠
炎症/感染
微生物学
发表日期：2023
文献求助 收藏

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.

在乌干达，快速、早期且强效的针对刺突蛋白的 IgG、IgM 和 IgA 可区分无症状 COVID-19 患者和轻症 COVID-19 患者，其中 IgG 可持续 28 个月

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1152522
Serwanga Jennifer, Ankunda Violet, Sembera Jackson, Kato Laban, Oluka Gerald Kevin, Baine Claire, Odoch Geoffrey, Kayiwa John, Auma Betty Oliver, Jjuuko Mark, Nsereko Christopher, Cotten Matthew, Onyachi Nathan, Muwanga Moses, Lutalo Tom, Fox Julie, Musenero Monica, Kaleebu Pontiano
信号转导
IGM
IgG
发表日期：2023
文献求助 收藏

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.

疫情前，乌干达样本中 SARS-CoV-2 特异性 IFN-γ 和抗体反应较低，HIV 阳性样本中则显著降低

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1148877
Nantambi Hellen, Sembera Jackson, Ankunda Violet, Ssali Ivan, Kalyebi Arthur Watelo, Oluka Gerald Kevin, Kato Laban, Ubaldo Bahemuka, Kibengo Freddie, Katende Joseph Ssebwana, Gombe Ben, Baine Claire, Odoch Geoffrey, Mugaba Susan, Sande Obondo James, Kaleebu Pontiano, Serwanga Jennifer
炎症/感染
新冠
发表日期：2023
文献求助 收藏